Novavax (NVAX) Non-Current Assets (2010 - 2026)

Novavax's Non-Current Assets history runs 17 years deep, the most recent figure standing at $192.3 million for Q1 2026.

• On a quarterly basis, Non-Current Assets fell 54.74% year-over-year to $192.3 million in Q1 2026; TTM through Mar 2026 was $1.0 billion, a 51.31% decrease from a year earlier, with the FY2025 full-year figure at $198.2 million, down 54.06% from the prior year.
• Non-Current Assets declined to $192.3 million in Q1 2026 per NVAX's latest filing, from $198.2 million in the prior quarter.
• Across five years, Non-Current Assets topped out at $653.6 million in Q4 2023 and bottomed at $192.3 million in Q1 2026.
• The 5-year median for Non-Current Assets is $507.5 million (2022), against an average of $481.8 million.
• Across the five-year window, Non-Current Assets surged 34.82% in 2022 and tumbled 66.28% in 2025, its largest moves.
• Year by year, Non-Current Assets stood at $555.3 million in 2022, then gained by 17.71% to $653.6 million in 2023, then plunged by 33.98% to $431.5 million in 2024, then tumbled by 54.06% to $198.2 million in 2025, then fell by 2.97% to $192.3 million in 2026.
• Per Business Quant, the three latest NVAX Non-Current Assets figures stand at $192.3 million (Q1 2026), $198.2 million (Q4 2025), and $205.3 million (Q3 2025).